12:00 AM
 | 
Oct 29, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Roche pipeline update

The European Commission may impose fines or periodic penalty payments on Roche if EMA finds that the pharma violated EU pharmacovigilance regulations by failing to report potential adverse events to health authorities....

Read the full 137 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >